Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone alone versus ceftriaxone + metronidazole for prevention of post-caesarean postoperative infections
PACTR202511775331231Phase 3Completed
- Sponsor
- AGBAGORO OGHENETEGA JESSE
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in surgical site infection (SSI) and endometritis comparing Ceftriaxone group with Ceftriaxone + metronidazole group (2 arms). Primary endpoints: Incidence of postoperative infections, Surgical site infection and 1 more. Started Feb 2025; status: completed.
02
Drugs
ceftriaxonemetronidazole
03
Conditions
surgical site infection (SSI)endometritis
Beyond the preview
Go deeper on PACTR202511775331231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202511775331231.